IMPROVING ONCOLOGY STUDY WITH INTEGRATED KRAS ASSAY SERVICES AND RAS ASSAYS

inside the quickly evolving field of oncology analysis, precise and effective mutation screening is vital for creating focused therapies. The KRAS companies Platform plays a pivotal part During this landscape by presenting extensive methods for KRAS mutation profiling and Assessment. KRAS mutations, located in around 95% of RAS-linked oncogenic alt